See more : Charms Industries Limited (CHARMS.BO) Income Statement Analysis – Financial Results
Complete financial analysis of 1Life Healthcare, Inc. (ONEM) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of 1Life Healthcare, Inc., a leading company in the Medical – Healthcare Information Services industry within the Healthcare sector.
- ZEUS NORTH AMERICA MINING CORP (ZUUZF) Income Statement Analysis – Financial Results
- SLM Corporation (SLM) Income Statement Analysis – Financial Results
- IVD Medical Holding Limited (1931.HK) Income Statement Analysis – Financial Results
- Valneva SE (0OB3.L) Income Statement Analysis – Financial Results
- Canterra Minerals Corporation (CTMCF) Income Statement Analysis – Financial Results
1Life Healthcare, Inc. (ONEM)
Industry: Medical - Healthcare Information Services
Sector: Healthcare
Website: https://www.onemedical.com
About 1Life Healthcare, Inc.
1Life Healthcare, Inc. operates a membership-based primary care platform under the One Medical brand. The company has developed a healthcare membership model based on direct consumer enrollment, as well as third-party sponsorship. Its membership model includes seamless access to 24/7 digital health services paired with inviting in-office care routinely covered under health insurance programs. The company also offers administrative and managerial services pursuant to contracts with physician-owned professional corporations or One Medical Entities. As of December 31, 2021, it had 703,000 consumer and enterprise members, and 33,000 At-Risk members; 182 medical offices in 25 markets; and 8,500 enterprise clients in the United States. The company was incorporated in 2002 and is headquartered in San Francisco, California.
| Metric | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|
| Revenue | 1.05B | 621.55M | 380.22M | 276.26M | 212.68M | 176.77M |
| Cost of Revenue | 861.16M | 435.18M | 234.96M | 167.62M | 136.18M | 120.71M |
| Gross Profit | 184.39M | 186.37M | 145.26M | 108.64M | 76.50M | 56.06M |
| Gross Profit Ratio | 17.64% | 29.98% | 38.20% | 39.33% | 35.97% | 31.72% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 415.83M | 323.13M | 157.28M | 108.97M | 85.81M | 57.96M |
| Selling & Marketing | 97.07M | 61.99M | 36.97M | 39.52M | 25.79M | 19.17M |
| SG&A | 512.90M | 385.12M | 194.25M | 148.49M | 111.60M | 77.14M |
| Other Expenses | 91.19M | 44.73M | 22.37M | 14.27M | 9.95M | 10.69M |
| Operating Expenses | 604.08M | 429.85M | 216.62M | 162.75M | 121.54M | 87.82M |
| Cost & Expenses | 1.47B | 865.04M | 451.58M | 330.37M | 257.72M | 208.53M |
| Interest Income | 2.02M | 798.00K | 1.81M | 4.50M | 2.25M | 386.00K |
| Interest Expense | 11.68M | 13.76M | 13.43M | 474.00K | 804.00K | 834.00K |
| Depreciation & Amortization | 91.19M | 46.50M | 22.37M | 24.50M | 9.95M | 10.69M |
| EBITDA | -326.50M | -196.19M | -53.03M | -27.49M | -33.64M | -19.15M |
| EBITDA Ratio | -31.23% | -31.56% | -13.95% | -9.95% | -15.82% | -10.83% |
| Operating Income | -417.68M | -242.69M | -71.36M | -54.11M | -45.05M | -31.76M |
| Operating Income Ratio | -39.95% | -39.05% | -18.77% | -19.59% | -21.18% | -17.97% |
| Total Other Income/Expenses | -11.68M | -13.76M | -18.19M | 505.00K | -430.00K | 198.00K |
| Income Before Tax | -429.36M | -256.44M | -89.54M | -53.61M | -45.48M | -31.56M |
| Income Before Tax Ratio | -41.07% | -41.26% | -23.55% | -19.41% | -21.38% | -17.85% |
| Income Tax Expense | -31.51M | -1.80M | -123.00K | 87.00K | 25.00K | 126.00K |
| Net Income | -397.85M | -254.64M | -88.72M | -52.55M | -44.42M | -30.80M |
| Net Income Ratio | -38.05% | -40.97% | -23.33% | -19.02% | -20.88% | -17.42% |
| EPS | -2.02 | -1.66 | -0.75 | -0.43 | -0.48 | -0.29 |
| EPS Diluted | -2.02 | -1.66 | -0.75 | -0.43 | -0.48 | -0.29 |
| Weighted Avg Shares Out | 197.05M | 153.70M | 118.38M | 122.41M | 91.66M | 104.62M |
| Weighted Avg Shares Out (Dil) | 197.05M | 153.70M | 118.38M | 122.41M | 91.66M | 104.62M |
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates ONEM, EPZM, LION
Amazon's One Medical Purchase Is The Genius Move Shareholders Have Been Hoping For
Can Amazon change healthcare? Experts sound off on tech giant's $3.9B deal to buy One Medical
Goldman Sachs, Morgan Stanley stand to cash in on $3.9 billion Amazon-One Medical deal
One Medical users vow to cancel memberships over $3.9 billion Amazon deal
Amazon already knows a lot about me, but One Medical takes it to a whole new level
One Medical users vow to cancel memberships over $3.9B Amazon deal
Amazon Buys One Medical
Amazon's One Medical acquisition sparks data privacy backlash: ‘What could go wrong?'
Amazon Makes Moves In Healthcare With Plans To Acquire One Medical
Source: https://incomestatements.info
Category: Stock Reports